GRAIL (NASDAQ:GRAL) Trading Down 4.2% - Time to Sell?

GRAIL, Inc. (NASDAQ:GRAL - Get Free Report) fell 4.2% during trading on Friday . The stock traded as low as $47.58 and last traded at $47.29. 471,147 shares traded hands during trading, a decline of 61% from the average session volume of 1,208,363 shares. The stock had previously closed at $49.38.

Analyst Upgrades and Downgrades

Several research analysts have recently weighed in on the stock. Morgan Stanley boosted their price target on shares of GRAIL from $16.00 to $20.00 and gave the company an "equal weight" rating in a research report on Tuesday, March 18th. Canaccord Genuity Group increased their price objective on GRAIL from $32.00 to $43.00 and gave the stock a "buy" rating in a research report on Wednesday, May 14th.

GRAIL Stock Down 1.7%

The business's 50-day simple moving average is $38.82 and its two-hundred day simple moving average is $31.61. The firm has a market capitalization of $1.75 billion and a price-to-earnings ratio of -0.80.

GRAIL (NASDAQ:GRAL - Get Free Report) last announced its earnings results on Tuesday, May 13th. The company reported ($3.10) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($4.03) by $0.93. GRAIL had a negative return on equity of 17.99% and a negative net margin of 1,464.53%. The company had revenue of $31.84 million for the quarter, compared to analyst estimates of $35.80 million. Sell-side analysts anticipate that GRAIL, Inc. will post -15.15 earnings per share for the current year.

Insider Activity

In other news, CFO Aaron Freidin sold 41,150 shares of the company's stock in a transaction on Friday, May 2nd. The stock was sold at an average price of $33.93, for a total transaction of $1,396,219.50. Following the sale, the chief financial officer now owns 294,020 shares of the company's stock, valued at approximately $9,976,098.60. This represents a 12.28% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, President Joshua J. Ofman sold 48,213 shares of the stock in a transaction on Friday, May 2nd. The shares were sold at an average price of $33.93, for a total value of $1,635,867.09. Following the completion of the sale, the president now owns 511,460 shares in the company, valued at approximately $17,353,837.80. The trade was a 8.61% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 183,398 shares of company stock valued at $6,222,694. 1.85% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the stock. Lindbrook Capital LLC acquired a new stake in GRAIL in the 4th quarter valued at about $28,000. State of Tennessee Department of Treasury purchased a new stake in shares of GRAIL during the fourth quarter worth approximately $28,000. Caldwell Sutter Capital Inc. acquired a new stake in GRAIL in the first quarter valued at approximately $28,000. Sterling Capital Management LLC purchased a new position in GRAIL in the fourth quarter worth approximately $29,000. Finally, Wellington Shields Capital Management LLC acquired a new position in GRAIL during the 4th quarter worth approximately $33,000.

About GRAIL

GRAIL, Inc operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.